Connect with us
Rui Santos Ivo, president of the National Authority for Medicines and Health Products IP (Infarmed), was elected president of the Board...
A comprehensive review of studies published in the International Journal of Molecular Sciences analyzed the influence of the endocannabinoid system (ECS) on the physiology and pathologies of the digestive tract...
Hexahydrocannabinol (HHC) is quickly emerging as one of the most discussed cannabinoids in the growing world of cannabis-derived compounds. In this article, we will explore its...
The non-profit organization 'We the Patients' is hosting the first meeting organized “by patients, for patients” in Zurich, Switzerland. After a successful launch...
Brennan Falcy is currently in the 5th year of a PhD program at the University of Massachusetts, Amherst, in the United States of America, where she is a neuroscientist...
Brazil's Superior Court of Justice (STJ) unanimously rejected the request to postpone the deadlines for regulating the cultivation of industrial hemp for...
Last week, CannaReporter® requested information from Infarmed – National Authority for Medicines and Health Products IP, after the withdrawal of some cosmetics with...
Infarmed – National Authority for Medicines and Health Products IP has ordered the immediate withdrawal from the market of several cosmetic products containing cannabidiol (CBD), arguing that...
HHC (hexahydrocannabinol) is a cannabinoid that can be either natural or semi-synthetic, depending on how it is obtained. Although it exists in small quantities in the...
The attempt to combat age-related cognitive decline through the use of cannabinoids is gaining more and more consistency. A preclinical study...
Watch the Documentary "Patients"
